0001752724-23-236084.txt : 20231025 0001752724-23-236084.hdr.sgml : 20231025 20231025080501 ACCESSION NUMBER: 0001752724-23-236084 CONFORMED SUBMISSION TYPE: N-CEN/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20231025 DATE AS OF CHANGE: 20231025 EFFECTIVENESS DATE: 20231025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PIONEER SERIES TRUST X CENTRAL INDEX KEY: 0001174520 IRS NUMBER: 030460956 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: N-CEN/A SEC ACT: 1940 Act SEC FILE NUMBER: 811-21108 FILM NUMBER: 231344033 BUSINESS ADDRESS: STREET 1: 60 STATE STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-742-7825 MAIL ADDRESS: STREET 1: 60 STATE STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: PIONEER FUNDAMENTAL GROWTH FUND DATE OF NAME CHANGE: 20051213 FORMER COMPANY: FORMER CONFORMED NAME: PIONEER LARGE CAP GROWTH FUND DATE OF NAME CHANGE: 20020530 0001174520 S000004137 Pioneer Fundamental Growth Fund C000011600 Pioneer Fundamental Growth Fund: Class A PIGFX C000011602 Pioneer Fundamental Growth Fund: Class C FUNCX C000075918 Pioneer Fundamental Growth Fund: Class Y FUNYX C000115405 Pioneer Fundamental Growth Fund: Class R PFGRX C000121111 Pioneer Fundamental Growth Fund: Class K PFGKX 0001174520 S000031914 Pioneer Corporate High Yield Fund C000099381 Pioneer Corporate High Yield Fund: Class A RCRAX C000099382 Pioneer Corporate High Yield Fund: Class C RCRCX C000099383 Pioneer Corporate High Yield Fund: Class Y RCRYX C000205106 Pioneer Corporate High Yield Fund: Class K 0001174520 S000031915 Pioneer Multi-Asset Ultrashort Income Fund C000099384 Pioneer Multi-Asset Ultrashort Income Fund: Class A MAFRX C000099385 Pioneer Multi-Asset Ultrashort Income Fund: Class C MCFRX C000099386 Pioneer Multi-Asset Ultrashort Income Fund: Class Y MYFRX C000123824 Pioneer Multi-Asset Ultrashort Income Fund: Class K MAUKX C000129913 Pioneer Multi-Asset Ultrashort Income Fund: Class C2 MAUCX N-CEN/A 1 primary_doc.xml X0404 N-CEN/A LIVE 0001174520 XXXXXXXX 811-21108 true false false N-1A S000031915 C000123824 C000099384 C000099385 C000129913 C000099386 S000004137 C000121111 C000011602 C000075918 C000115405 C000011600 S000031914 true Pioneer Series Trust X 811-21108 0001174520 549300OT70Y6XDA91822 60 State Street Boston 02109-1820 US-MA US 617-422-4947 Brown Brothers Harriman & Co. 50 Post Office Sq Boston 02110-1548 617-772-1818 Books and records N N N-1A 2 Y Thomas J. Perna N/A N John E. Baumgardner, Jr. N/A N Lorraine H. Monchak N/A N Craig C. MacKay 002008771 N Lisa M. Jones N/A Y Diane Durnin 004798101 N Kenneth J. Taubes N/A Y Marguerite A. Piret N/A N Benjamin M. Friedman N/A N Fred J. Ricciardi N/A N John Malone 002314031 60 State Street Boston 02109-1820 XXXXXX N N N N N N N Amundi Distributor US, Inc. 8-41256 000024497 549300OSI141GCUW7776 Y N ERNST & YOUNG LLP 42 254900H1VLSDPE6LJK37 N N N N N N N Pioneer Multi-Asset Ultrashort Income Fund S000031915 IC2ZQHJKYFJZRN7PPX71 N 5 0 0 N/A N N N N N/A N/A N/A Rule 22d-1 (17 CFR 270.22d-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 32a-4 (17 CFR 270.32a-4) Rule 10f-3 (17 CFR 270.10f-3) N N N N Amundi Asset Management US, Inc. 801-8255 000107719 GVETZ2DEF39OCQ4SSX41 N DST ASSET MANAGER SOLUTIONS, INC. 84-00896 N/A N N N Bear Stearns 549300L8HTN2UIEXSQ93 N Bank of America Corp. 9DJT3UXIJIZJI4WXO774 N IHS Markit Group Holdings Limited 2138005LTLTVZ4WMEX25 GB N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N Refinitiv US LLC 213800HQORQAP68CJJ04 N Y HSBC BANK AUSTRALIA LIMITED FOR THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED (HSBC) DY9DBNI4W8J63Z298033 AU N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) EUROCLEAR BK SA NV 549300OZ46BRLZ8Y6F65 BE N Y Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7) SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) F3JS33DEI6XQ4ZBPTN86 SE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) NORDEA BANK ABP, FILIAL I NORGE 529900ODI3047E2LIV03 NO N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) HSBC BANK PLC MP6I5ZYZBEU3UXPYFY54 GB N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N DST ASSET MANAGER SOLUTIONS, INC. 84-00896 SEC Number N N N Amundi Asset Management US, Inc. GVETZ2DEF39OCQ4SSX41 Y N Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N Y N Amundi Distributor US, Inc. 008-41256 000024497 549300OSI141GCUW7776 0.00000000 Credit Agricole Securities (USA) Inc. 008-13753 000000190 549300WO2DKF0Q3YMV43 0.00000000 0.00000000 TD Securities (USA) LLC. 008-36747 000018476 SUVUFHICNZMP2WKHG940 4086845960.00000000 J.P. MORGAN SECURITIES LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 1399859928.00000000 DEUTSCHE BANK SECURITIES INC. 008-17822 000002525 9J6MBOOO7BECTDTUZW19 1050698938.00000000 Citigroup Global Markets Inc. 008-08177 000007059 MBNUM2BPBDO7JBLYG310 1407038464.00000000 ROYAL BANK OF CANADA N/A 000031194 ES7IP3U3RHIGC71XBU11 CA 4319791211.00000000 BANK OF NOVA SCOTIA N/A N/A L3I9ZG2KFGXZ61BMYR72 CA 3862095000.00000000 MERRILL LYNCH, PIERCE, FENNER & SMITH INC. 008-07221 000007691 8NAV47T0Y26Q87Y0QP81 8754859852.00000000 BARCLAYS CAPITAL INC. 008-41342 000019714 AC28XWWI3WIBK2824319 1539827237.00000000 BNY MELLON CAPITAL MARKETS, LLC 008-35255 000017454 VJW2DOOHGDT6PR0ZRO63 1068360960.00000000 Wells Fargo Securities LLC 008-65876 000126292 VYVVCKR63DVZZN70PB21 2938576107.00000000 35735885763.00000000 N 4709860420.77000000 Committed 450000000.00000000 N N N N Pioneer Fundamental Growth Fund S000004137 549300YST2IRKGKOMC34 N 5 0 0 N/A N N N N N/A N/A N/A Rule 22d-1 (17 CFR 270.22d-1) Rule 32a-4 (17 CFR 270.32a-4) Y N N N Amundi Asset Management US, Inc. 801-8255 000107719 GVETZ2DEF39OCQ4SSX41 N DST ASSET MANAGER SOLUTIONS, INC. 84-00896 N/A N N N Refinitiv US LLC 213800HQORQAP68CJJ04 N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N N Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N DST ASSET MANAGER SOLUTIONS, INC. 84-00896 SEC Number N N N Amundi Asset Management US, Inc. GVETZ2DEF39OCQ4SSX41 Y N Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N Y N Amundi Distributor US, Inc. 008-41256 000024497 549300OSI141GCUW7776 0.00000000 Credit Agricole Securities (USA) Inc. 008-13753 000000190 549300WO2DKF0Q3YMV43 0.00000000 Citigroup Global Markets Inc. 008-08177 000007059 MBNUM2BPBDO7JBLYG310 12444.07000000 Goldman Sachs & Co, LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 12307.72000000 SANFORD C. BERNSTEIN & CO., LLC 008-52942 000104474 549300I7JYZHT7D5CO04 50073.82000000 Piper Sandler LTD. N/A 000163758 2138008LHD1TOYE4JE90 GB 110335.77000000 INSTINET, LLC 008-23669 000007897 549300MGMN3RKMU8FT57 298777.32000000 KeyBanc Capital Markets Inc. 008-30177 000000566 2EQWV0180Z211YVAD813 44894.85000000 MERRILL LYNCH, PIERCE, FENNER & SMITH INC. 008-07221 000007691 8NAV47T0Y26Q87Y0QP81 53889.42000000 CAPITAL INSTITUTIONAL SERVICES, INC. 008-22273 000007551 54930061X8RDWFDJIS05 66511.53000000 LIQUIDNET INC. 008-52461 000103987 213800HSKBBO1GCVRG79 41559.16000000 FIDELITY MANAGEMENT & RESEARCH COMPANY N/A 000108281 5493001Z012YSB2A0K51 28452.52000000 806978.75000000 J.P. MORGAN SECURITIES LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 34995926.00000000 BANK OF NOVA SCOTIA N/A N/A L3I9ZG2KFGXZ61BMYR72 CA 419535000.00000000 ROYAL BANK OF CANADA N/A 000031194 ES7IP3U3RHIGC71XBU11 CA 335190000.00000000 BANK OF AMERICA CORPORATION N/A 000112613 9DJT3UXIJIZJI4WXO774 226640000.00000000 TD Securities (USA) LLC. 008-36747 000018476 SUVUFHICNZMP2WKHG940 885870000.00000000 Citigroup Global Markets Inc. 008-08177 000007059 MBNUM2BPBDO7JBLYG310 39997836.00000000 1942228762.00000000 Y 6397976208.45000000 Committed 450000000.00000000 N N N N true true OTHER REQUIRED INFO 2 explanatory_note_2023.htm

Form: N-CEN/A

Explanation:

This amendment is being filed to address incorrect or omitted responses from the original submission.

 INTERNAL CONTROL RPT 3 82550_ncen_PSTX.htm AUDITOR'S LETTER

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Trustees of
Pioneer Series Trust X:

In planning and performing our audit of the financial statements of Pioneer Fundamental Growth Fund and Pioneer Multi-Asset Ultrashort Income Fund (the “Funds”) (two funds constituting Pioneer Series Trust X) as of and for the year ended March 31, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds’ internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds’ internal control over financial reporting.  Accordingly, we express no such opinion.

The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Funds’ internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no
deficiencies in the Funds’ internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be a material weakness as defined above as of March 31, 2021.

This report is intended solely for the information and use of management and the Board of Trustees of Pioneer Series Trust X, and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.


                                                                /s/ ERNST & YOUNG LLP                                  

Boston, Massachusetts
May 27, 2021